Super Religare Laboratories to market miRview tests in India and the Middle East
Super Religare Laboratories Limited (SRL) is India’s largest diagnostics network, and it has signed an exclusive marketing agreement with Rosetta Genomics for the distribution of miRview tests in India, Qatar, Saudi Arabia and the United Arab Emirates (UAE). The samples collected in SRL’s territories will be sent to Rosetta Genomics’ CLIA-certified lab in Philadelphia, Pennsylvania for analysis. The miRview tests include miRview meso, a test to differentiate mesothelioma from carcinomas in the lung.
For the full story, go to Express Healthcare.
![[Information package]](http://www.mesotheliomanews.com/wp-content/themes/biromeso/images/infopack.jpg)
